$EYPT EyePoint Pharmaceuticals, Inc. Insider Trading
Get free email notifications about insider trading in EyePoint Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in EyePoint Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in EyePoint Pharmaceuticals, Inc. for free.
CIK Number: 0001314102
IRS Number: 262774444
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Trading Symbol: EYPT
Company Address: 480 PLEASANT STREET SUITE B300 WATERTOWN 02472
Phone number: 617-926-5000
Former name: pSivida LTD, date of change: 2005-01-11
Former name: pSivida Corp., date of change: 2008-06-19
Market Capitalization: $60.15M
Prev close: $1.66
Average Daily Volume: 160,718
Days Low: $1.72
Year Low: $1.50
Year High: $4.25
EyePoint Pharmaceuticals, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 23 2021 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | A | 13.13 | 60,300 | 791,739 | 60,300 | |
Jun 23 2021 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | A | 0.00 | 14,900 | 0 | 14,900 | |
Jun 23 2021 | EYPT | EyePoint Pharmaceu ... | Elston George | Chief Financial Off ... | Option Exercise | A | 13.13 | 60,300 | 791,739 | 60,300 | |
Jun 23 2021 | EYPT | EyePoint Pharmaceu ... | Elston George | Chief Financial Off ... | Option Exercise | A | 0.00 | 14,900 | 0 | 14,900 | |
Feb 23 2021 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 13,717 | 0 | 13,718 | |
Feb 23 2021 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Buy | M | 0.00 | 13,717 | 0 | 96,579 | 82.9 K to 96.6 K (+16.55 %) |
Sep 09 2020 | EYPT | EyePoint Pharmaceu ... | Elston George | Chief Financial Off ... | Buy | P | 0.48 | 10,000 | 4,800 | 40,000 | 30 K to 40 K (+33.33 %) |
Aug 26 2020 | EYPT | EyePoint Pharmaceu ... | Elston George | Chief Financial Off ... | Buy | P | 0.61 | 10,000 | 6,112 | 30,000 | 20 K to 30 K (+50.00 %) |
Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Jones David Scott | SVP & Chief Commerc ... | Option Exercise | M | 0.00 | 41,050 | 0 | 82,100 | |
Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Jones David Scott | SVP & Chief Commerc ... | Payment of Exercise | F | 0.76 | 14,060 | 10,643 | 26,990 | 41.1 K to 27 K (-34.25 %) |
Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Jones David Scott | SVP & Chief Commerc ... | Buy | M | 0.00 | 41,050 | 0 | 41,050 | 0 to 41.1 K |
Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Option Exercise | M | 0.00 | 41,050 | 0 | 82,100 | |
Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Payment of Exercise | F | 0.76 | 12,049 | 9,121 | 89,144 | 101.2 K to 89.1 K (-11.91 %) |
Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Paggiarino Dario A. | Chief Medical Offic ... | Buy | M | 0.00 | 41,050 | 0 | 101,193 | 60.1 K to 101.2 K (+68.25 %) |
Jul 02 2020 | EYPT | EyePoint Pharmaceu ... | Lurker Nancy | President & CEO | Option Exercise | M | 0.00 | 124,667 | 0 | 249,333 |
View all EyePoint Pharmaceuticals, Inc. insider transactions.